Page 111 - ECBIP 2021_Program
P. 111

                                               6th European Congress
for Bronchology and Interventional Pulmonology
OCTOBER ECBIP 15 - 17
ATHENS - GREECE 2021
Sponsors’ Section
    ECBIP CONGRESS 2021 – ATHENS
JOIN OUR SYMPOSIUM &
HANDS-ON WORKSHOP
Sunday, October 17 | 08:30 am – 10:30 am
 HANDS-ON WORKSHOP
Zephyr® Valves for Endoscopic Lung Volume Reduction
Sunday, October 17 | 8:30 am – 9:30 am
Learn and Practice how to place the Zephyr Endobronchial valves
Instructors: Dr. med. Michela Bezzi | Brescia & Dr. med. Konstantina Kontogianni | Heidelberg
 SYMPOSIUM
Endoscopic Lung Volume Reduction – State of the Art
Sunday, October 17 | 9:30am – 10:30 am
09:30 – 09:45 09:45 – 10:05
10:05 – 10:15 10:20 – 10:30
Introduction: Facts & Figures | Prof. Daniela Gompelmann, Vienna Endoscopic Lung Volume Reduction with the Zephyr® Valve: How to do it? | Prof. Dirk-Jan Slebos, Groningen
Case studies | Prof. Daniela Gompelmann, Vienna
Q&A | Prof. Daniela Gompelmann, Vienna & Prof. Dirk-Jan Slebos, Groningen
Pulmonx International Sàrl
Rue de la Treille 4, 2000 Neuchâtel, Switzerland Telephone: +41 32 475 20 70 | Fax: +41 32 475 20 71 Email: info@pulmonx.com
Visit our website: www.pulmonx.com
Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death. Brief Statement: The Zephyr Endobronchial Valve is an implantable bronchial valve intended to control airflow in order to improve lung functions in patients with hyperinflation associated with severe emphysema with little to no collateral ventilation, and/or to reduce air leaks. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; Evidence of active pulmonary infection; Patients with known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); Patients with known allergies to silicone; Patients who have not quit smoking. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
© 2021 Pulmonx Corporation or its affiliates. All rights reserved. All trademarks are property of their respective owners. EUR-EN-1131-v1 ECBIP 2021 invite & ad Sept. 2021
  ECBIP 2021 111
     






































































   109   110   111   112   113